Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBERICA: ATG-Fresenius in Steroid-Free Renal Transplantation
NCT01324934Phase 3Terminated
- Sponsor
- Neovii Pharmaceuticals
- Start
- Oct 2006
- Primary completion
- Jan 2011
- Countries
- 2
01
Overview
A Phase 3 trial of grafalon in renal transplant rejection (RTR), sponsored by Neovii Pharmaceuticals. Started Oct 2006; status: terminated.
02
Drugs
grafalon
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT01324934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01324934.